Timoptol Xe Discontinued

Less than 1% of patients discontinued Timoptol – XE due to transient blurred vision. The following possibly, probably, or definitely drug-related adverse reactions occurred with frequency of at least 1% in active treatment controlled clinical trials: Ocular. Common (? 1% and < 10%). Blurred vision, burning and stinging, conjunctival injection ...symptom of cardiac failure TIMOPTOL - XE should be discontinued . NEW ZEALAND DATA SHEET TIMOPTOL - XE ® TIM-XE002 18 Mar 2020 Page 4 of 14 Surgical Anaesthesia The necessity or desirability of withdrawal of beta-adrenergic blocking agents prior to major surgery is controversial. If necessary during surgery, the effects of beta-adrenergic blocking ...TIMOPTOL - XE started on the following day. When a patient is transferred from another topical ophthalmic beta-adrenergic blocking agent, that agent should be discontinued after proper dosing on one day and treatment with TIMOPTOL - XE started on the following day with 1 drop of 0.25% TIMOPTOL - XE in the affected eye once a day.The usual dose for adults is one drop of TIMOPTOL - XE once a day, in either one or both eyes. TIMOPTOL - XE contains a new delivery vehicle, gellangum. This vehicle allows the eye drop to form a clear gel when it contacts the eye. This gel increases the contact time of timolol maleate with the eye. This means TIMOPTOL - XE needs to be administered only, to TIMOPTOL - XE ®, TIMOPTOL ® should be discontinued after proper dosing on one day, and treatment with the same concentration of TIMOPTOL - XE ® started on the following day. When a patient is transferred from another topical ophthalmic beta-adrenergic blocker, that medicine should be discontinued after proper dosing on one day and treatment ...At the first sign or symptom of cardiac failure, Timoptol should be discontinued . Cardiac failure should be adequately controlled before beginning therapy with Timoptol . Patients with a history of cardiovascular disease, including cardiac failure should be watched for signs of deterioration of these diseases, and pulse rates should be checked.5/31/2016  · TIMOPTIC- XE Sterile Ophthalmic Gel Forming Solution is supplied as a sterile, isotonic, buffered, aqueous solution of timolol maleate in two dosage strengths. The pH of the solution is approximately 7.0, and the osmolarity is 260-330 mOsm. Each mL of TIMOPTIC- XE 0.25% contains 2.5 mg of timolol (3.4 mg of timolol maleate).Consumer Medicine InformationWhat is in this leafletThis leaflet answers some common questions about TIMOPTOL - XE . It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist.All medicines have risks and benefits. Your doctor has weighed the risks of you using TIMOPTOL - XE against the benefits they expect it.Purpose: To compare the efficacy and safety of timolol hemihydrate 0.5% (Betimol, Ciba Vision Ophthalmics, Duluth, Georgia) vs timolol maleate gel-forming solution 0.5% (Timoptic- XE , Merck, Blue Bell, Pennsylvania), both given every morning added to latanoprost 0.005% given every evening. Methods: A multicenter, randomized, crossover comparison was performed in.After the discontinuation of Timoptol XE eye drops and Latanoprost eye drops, Tarivid ophthalmic ointment (left eye, once daily) was prescribed. After 2 days, the corneal disorder improved, and, after 34 days, an instruction was given to resume the administration of only Timoptol XE eye drops into the left eye.